{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:47:17Z","timestamp":1789012037287,"version":"build-2803163510"},"reference-count":18,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rare hematologic malignancies display evidence of both myeloid and lymphoid differentiation. Here, we describe such a novel bilineal event discovered in an adult woman with B-lymphoblastic leukemia (BLL). At the time of BLL diagnosis, the patient had a normal karyotype and a bulk sequencing panel identified pathogenic variants in BCOR, EZH2, RUNX1, and U2AF1, a genotype more typical of myeloid neoplasia. Additionally, the patient was noted to have 3-year history of cytopenias, and morphologic dyspoiesis was noted on post-treatment samples, raising the possibility of an antecedent hematologic disorder. To investigate the clonal architecture of her disease, we performed targeted sequencing on fractionated samples enriched for either B-lymphoblasts or circulating granulocytes. These studies revealed a truncal founder mutation in the spliceosome gene U2AF1 in both fractions, while distinct secondary mutations were present only in B-lymphoblasts (BCOR, NRAS) or myeloid cells (ASXL1, EZH2, RUNX1). These results indicate that both processes evolved from a common U2AF1-mutated precursor, which then acquired additional mutations during a process of divergent evolution and bilineal differentiation. Our findings highlight an atypical mechanism of BLL leukemogenesis and demonstrate the potential utility of fractionated sequencing in the characterization of acute leukemia.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005308","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T13:10:11Z","timestamp":1632834611000},"page":"5612-5616","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Bilineal evolution of a <i>U2AF1<\/i>-mutated clone associated with acquisition of distinct secondary mutations"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1765-6623","authenticated-orcid":false,"given":"Nathan D.","family":"Montgomery","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Galeotti","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Commander","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3677-5724","authenticated-orcid":false,"given":"Eric T.","family":"Weimer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranil K.","family":"Chandra","sequence":"additional","affiliation":[{"name":"PathGroup, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Nazir","sequence":"additional","affiliation":[{"name":"Cape Fear Valley Cancer Treatment Center, Fayetteville, NC and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-1574","authenticated-orcid":false,"given":"Thomas B.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, Department of Pediatrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-1514","authenticated-orcid":false,"given":"Joshua F.","family":"Zeidner","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Foster","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"issue":"12","key":"2021122816205311200_B1","first-page":"1211","article-title":"The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in \u201clymphoid\u201d blasts and A comparison of morphologic, immunophenotypic, and molecular findings","volume":"11","author":"Khalidi","year":"1998","journal-title":"Mod Pathol."},{"key":"2021122816205311200_B2","first-page":"180","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Borowitz","year":"2017","edition":"4th ed"},{"issue":"1","key":"2021122816205311200_B3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1998.00542.x","article-title":"\u2018Lymphoid\u2019 blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features","volume":"100","author":"Cervantes","year":"1998","journal-title":"Br J Haematol."},{"issue":"2","key":"2021122816205311200_B4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.leukres.2005.06.011","article-title":"Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology","volume":"30","author":"Disperati","year":"2006","journal-title":"Leuk Res."},{"issue":"3","key":"2021122816205311200_B5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1986.tb02204.x","article-title":"Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype","volume":"64","author":"Bonati","year":"1986","journal-title":"Br J Haematol."},{"issue":"6","key":"2021122816205311200_B6","first-page":"9745","article-title":"Acute pro-B-cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: a case report with literature review","volume":"15","author":"Guo","year":"2018","journal-title":"Oncol Lett."},{"issue":"10","key":"2021122816205311200_B7","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia."},{"issue":"1","key":"2021122816205311200_B8","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1038\/s41467-019-10737-5","article-title":"Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data","volume":"10","author":"Malikic","year":"2019","journal-title":"Nat Commun."},{"issue":"21","key":"2021122816205311200_B9","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood."},{"issue":"9","key":"2021122816205311200_B10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","article-title":"Acute myeloid leukemia ontogeny is defined by distinct somatic mutations","volume":"125","author":"Lindsley","year":"2015","journal-title":"Blood."},{"issue":"2","key":"2021122816205311200_B11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000101710","article-title":"Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS","volume":"74","author":"Dirnhofer","year":"2007","journal-title":"Pathobiology."},{"key":"2021122816205311200_B12","first-page":"98","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Hasserjian","year":"2017","edition":"4th ed"},{"issue":"25","key":"2021122816205311200_B13","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood."},{"issue":"40","key":"2021122816205311200_B14","doi-asserted-by":"crossref","first-page":"65485","DOI":"10.18632\/oncotarget.11796","article-title":"Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations","volume":"7","author":"Spinella","year":"2016","journal-title":"Oncotarget."},{"issue":"D1","key":"2021122816205311200_B15","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021122816205311200_B16","author":"Catalogue Of Somatic Mutations In Cancer (COSMIC)"},{"issue":"24","key":"2021122816205311200_B17","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1182\/bloodadvances.2019000925","article-title":"Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes","volume":"3","author":"Saygin","year":"2019","journal-title":"Blood Adv."},{"issue":"18","key":"2021122816205311200_B18","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2016-07-725861","article-title":"Distinct bilineal leukemia immunophenotypes are not genetically determined","volume":"128","author":"Kotrova","year":"2016","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/24\/5612\/1855925\/advancesadv2021005308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/24\/5612\/1855925\/advancesadv2021005308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T16:21:19Z","timestamp":1640708479000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/24\/5612\/477048\/Bilineal-evolution-of-a-U2AF1-mutated-clone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":18,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005308","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}